Sugammadex to prevent postoperative nausea and vomiting?
Rev. bras. anestesiol; 68 (3), 2018
Results: 4
Complicación respiratoria en el postoperatorio tardío en un paciente con distrofia miotónica tipo I. Reporte de un caso
Rev. chil. anest; 47 (3), 2018
Myotonic dystrophy is an uncommon disease, characterised by disorders of the muscle membrane. Its clinical manifestations are muscle weakness, difficulty at initiating movements and delayed muscle relaxation. Carriers of this disease are very sensitive to anaesthetic drugs. Residual neuromuscular blockad...
Distrofia Miotónica/cirugía, Enfermedades Respiratorias/inducido químicamente, Complicaciones Posoperatorias/inducido químicamente, Bloqueantes Neuromusculares/efectos adversos, Complicaciones Posoperatorias/tratamiento farmacológico, Rocuronio/uso terapéutico, Sugammadex/uso terapéutico, Fármacos Neuromusculares Despolarizantes/uso terapéutico
Comparison of the effects of sugammadex and neostigmine on postoperative nausea and vomiting
Rev. bras. anestesiol; 67 (2), 2017
Abstract Background and objectives: The aim of our study is to compare the effects of sugammadex and neostigmine, used for neuromuscular blockage antagonism, on postoperative nausea and vomiting (PONV). Methods: Our study was completed with 98 ASA I-II risk patients undergoing endotracheal intubation u...
Successful use of sugammadex for caesarean section in a patient with myasthenia gravis
Rev. bras. anestesiol; 67 (2), 2017
Abstract Myasthenia gravis is an autoimmune disorder that is characterized by muscle weakness that fluctuates, worsening with exertion, and improving with rest. Diagnosis of myasthenia gravis is made following clinical and physical examination and is confirmed by serum immunoassays to measure autoantibod...